Agency / Source: Becton, Dickinson and Company

Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

BD Expands Genomics Portfolio with New Single Cell Platform for RNA Expression Analysis - BD Rhapsody™ single cell analysis system launches for gene expression profiling, plans to expand for protein analysis - BD.com
BD Expands Genomics Portfolio with New Single Cell Platform for RNA Expression Analysis

 

PRZOOM - /newswire/ - Franklin Lakes, NJ, United States, 2017/09/12 - BD Rhapsody™ single cell analysis system launches for gene expression profiling, plans to expand for protein analysis - BD.com. NYSE: BDX

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services/Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

BD (Becton, Dickinson and Company), a leading global medical technology company, today announced the launch of BD Rhapsody, a platform for single cell analysis with the ability to detect rare molecules responsible for biological diversity that are often missed with whole transcriptome profiling.

Developed using the company’s patented unique molecular index (UMI) technology, BD Rhapsody is a complete system of reagents, instruments and software for targeted gene expression analysis of tens of thousands of individual cells. The product was previously in limited commercial release under the name Resolve. BD will offer both application-specific targeted panels and enable customers to design their own custom, targeted panels.

“Early access users have been enthusiastic about our targeted assay solution and its superior performance compared to whole transcriptome profiling,” said Stephen Gunstream, vice president of Genomics for BD. “These same users have also experienced considerable sequencing cost savings from this technology.”

The BD Rhapsody platform assay offering will be rapidly expanded over the next 12 months. Shortly after launch, customers will be able to multiplex many samples in one run with the BD single-cell multiplexing kit, significantly increasing sample throughput while maintaining the low doublet rate. The platform is also being expanded beyond RNA expression to include protein detection, leveraging BD’s extensive antibody portfolio with BD AbSeq assays for protein expression.

“Initial data generated looks extremely positive and we believe true understanding of complex diseases will come with the ability to interrogate both protein and RNA in single cells simultaneously,” Gunstream added.

BD has initiated early access for AbSeq protein detection on the BD Rhapsody system and expects commercial availability in the first half of 2018. The BD Rhapsody system and AbSeq assays will be showcased at this year’s AGBT Precision Health and ASHG conferences.

These new products build on BD’s 40-year history of providing solutions for single cells using flow cytometry. With the BD Rhapsody system, researchers are able to easily discover both the gene expression and protein markers that more completely identify their cell population of interest.

Join BD at the AGBT meeting on Friday, Sept. 15 from 6:30 to 8:30 pm. or on Saturday, Sept. 16 from 12:45 to 1 pm. in the Camelback Ballroom for the workshop, BD Rhapsody system and AbSeq: Simultaneous RNA and protein analysis on tens of thousands of single cells.

The BD Rhapsody system (bd.com/Rhapsody) is for research use only and not for diagnostic or therapeutic use.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services/Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: Becton, Dickinson and Company

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker

 

Distribution / Indexing: [+]  / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Medical Services/Equipment articles,
CATCH Visitors via Your Competitors Announcements!


BD Expands Genomics Portfolio with New Single Cell Platform for RNA Expression Analysis

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
BD Rhapsody™ | BD
Contact: Gwen Gordon / Monique N. Dolecki - BD.com 
858-812-3724 / 201-847-5378 gwen.gordon[.]bd.com / monique_dolecki[.]bd.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Becton, Dickinson and Company securities in any jurisdiction including any other companies listed or named in this release.

Medical Services/Equipment via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Press Releases From Becton, Dickinson and Company / Company Profile


Read Medical Services/Equipment Most Recent Related Press Releases:

Cutting-Edge micro-CT Imaging Research Shines New Light on Mooted SARS-CoV-2 Treatments
Bruker Launches Revolutionary High-Speed AFM System for Single-Molecule Applications
Bruker Launches Second-Generation FluoroType® SARS-CoV-2 plus PCR Test for Detection of SARS-CoV-2 Viral Infections in Europe
SCHOTT Launches New VisiLED UV Ring Light for Stereo Microscopy
Citizen Care Pod Corp. Collaborates with WZMH Architects, PCL Construction, Insight Enterprises and Microsoft to Launch A Custom Mobile Testing Unit
American Regent Inc. Selects Sparta Systems’ TrackWise Digital QMS to Seamlessly Connect Quality Across Manufacturing, Clinical and Supplier Network
Frost & Sullivan Analyzes the Future of Adhesion Prevention Products in the US and EU5
FORA Auto Temperature Measurement Station Provides Protection During COVID-19
TPEs Introduces A Range of TPE-compounds for Direct Contact with Blood and Body Fluid Applications in the Medical Sector
Safran and Segula Technologies Continue to Support the Fight Against Covid-19 by Adapting Decathlon’s Easybreath Subea Mask for Use in Hospitals

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
 
NewswireToday Celebrates 10 Years in Business
.



PREMIUM Members


Visit  Limelon Advertising, Co.

Visit  JobsWare.com

Visit  BizJobs.com







 
  ©2020 PRZOOM - Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today